PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
149.60%
Cash & equivalents yoy growth at least 1.5x TRAW's 1.60%. Mohnish Pabrai might see this as a favorable liquidity edge, provided funds are well deployed.
No Data
No Data available this quarter, please select a different quarter.
149.60%
Below half of TRAW's -16.69%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
133.42%
Below half of TRAW's -17.07%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
835.01%
≥ 1.5x TRAW's 9.34%. David Dodd sees more aggressive capex. Confirm it's not overspending.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1079.37%
≥ 1.5x TRAW's 7.49%. David Dodd sees significantly higher long-term asset buildup. Confirm synergy with strategy.
No Data
No Data available this quarter, please select a different quarter.
135.47%
Below half of TRAW's -16.88%. Michael Burry sees a potential red flag for stagnation or capital shortage.
69.91%
1.25-1.5x TRAW's 52.24%. Martin Whitman sees potential reliance on supplier financing. Verify liquidity.
-41.82%
Higher Short-Term Debt Growth compared to TRAW's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-49.13%
Less than half of TRAW's 13.00%. David Dodd sees fewer expansions in other current obligations.
-44.50%
Less than half of TRAW's 3.38%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-44.50%
Less than half of TRAW's 1.09%. David Dodd sees far fewer liability expansions relative to competitor.
7.98%
Higher Common Stock (Book Value) Growth compared to TRAW's zero value, indicating worse performance.
4.22%
Below half TRAW's -6.71%. Michael Burry suspects major net losses or high dividends vs. competitor.
-271.57%
Higher AOCI Growth compared to TRAW's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
132.15%
Below half TRAW's -24.09%. Michael Burry sees potential underperformance in building shareholder capital.
135.47%
Below half TRAW's -16.88%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-41.82%
Higher Total Debt Growth compared to TRAW's zero value, indicating worse performance.
-152.72%
Above 1.5x TRAW's -1.60%. Michael Burry sees a major gap in net debt growth. Check coverage and liquidity.